At a glance
ClinicalIndex Comparison RecordN/ACompleted· 31 enrolled
Drug / intervention
TauTona Pneumoperitoneum Assist Device (TPAD) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study to Establish Safety and Ease of Use of a TauTona Pneumoperitoneum Assist Device (TPAD) for Laparoscopic Surgery
In Brief
A clinical study evaluating TauTona Pneumoperitoneum Assist Device (TPAD) and Standard of Care (SOC) for Laparoscopic Surgery. Completed, enrolled 31 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the safety and ease of use of a TauTona Pneumoperitoneum Assist Device (TPAD) to assist with obtaining peritoneal access with a Veress needle, and for placing a primary trocar, during laparoscopic surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLaparoscopic Surgery
CountriesUnited States
CollaboratorsTauTona Group
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMay 2020
Enrollment StartJun 2022
Primary CompletionJun 2024
TodayJul 2026
First PostedMay 19, 2020
Enrollment StartJun 20, 2022
Primary CompletionJun 17, 2024
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 6.1 years ago
Interventions
TauTona Pneumoperitoneum Assist Device (TPAD)device
The TPAD is an experimental device used to assist with placement of Veress needle during laparoscopic surgery.
Standard of Care (SOC)procedure
Standard of Care was used for Veress needle insertion.